🇺🇸 FDA
Patent

US 11008337

Chiral diaryl macrocycles as modulators of protein kinases

granted A61PA61P25/00A61P29/00

Quick answer

US patent 11008337 (Chiral diaryl macrocycles as modulators of protein kinases) held by TURNING POINT THERAPEUTICS, INC. expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P25/00, A61P29/00, A61P35/00, A61P37/00